- AU$3.72bn
- AU$4.21bn
- AU$1.65bn
- 71
- 66
- 66
- 74
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,078 | 1,728 | 1,562 | 1,771 | 1,646 |
Cost of Revenue | |||||
Gross Profit | 870 | 672 | 595 | 776 | 591 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,209 | 1,021 | 1,120 | 1,041 | 1,060 |
Operating Profit | 869 | 707 | 442 | 730 | 586 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 810 | 693 | 437 | 717 | 559 |
Provision for Income Taxes | |||||
Net Income After Taxes | 577 | 501 | 317 | 501 | 401 |
Net Income Before Extraordinary Items | |||||
Net Income | 577 | 501 | 317 | 501 | 401 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 577 | 501 | 317 | 501 | 401 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.247 | 0.202 | 0.165 | 0.219 | 0.17 |
Dividends per Share |